系统综述与Meta分析:幽门螺杆菌的全球复发率
该系统综述与Meta分析纳入132项研究(共53,934患者年),评估幽门螺杆菌根除治疗后全球复发率。全球年复发率、再感染率和复燃率分别为4.3%(95%CI 4-5)、3.1%(95%CI 2-5)和2.2%(95%CI 1-3)。复发率与人类发展指数(HDI)呈负相关(P<.01),与幽门螺杆菌本地感染率呈正相关(P<.01)。
要点
- 全球幽门螺杆菌年复发率为4.3%(95%CI 4-5),年再感染率为3.1%(95%CI 2-5)。
- 年复发率在HDI极高、高、中或低国家分别为3.1%(95%CI 2-4)、6.2%(95%CI 4-8)和10.9%(95%CI 6-18)(P<.01)。
- 年复发率在幽门螺杆菌感染率极高、高、中、低国家分别为10.9%(95%CI 7-16)、3.7%(95%CI 3-5)、3.4%(95%CI 2-5)和1.6%(95%CI 0.5-3)(P<.01)。
核心结论
- 幽门螺杆菌复发仍是与 socioeconomic 和卫生条件密切相关的问题,发展中国家需要降低复发的方法。
研究设计与样本
- 系统检索PubMed、EMBASE和Cochrane图书馆,纳入132项研究,共53,934患者年,按患者年数加权分析。
主要发现
- 全球幽门螺杆菌年复发率为4.3%(95%CI 4-5),年再感染率为3.1%(95%CI 2-5),年复燃率为2.2%(95%CI 1-3)。
- 年复发率在HDI极高、高、中或低国家分别为3.1%(95%CI 2-4)、6.2%(95%CI 4-8)和10.9%(95%CI 6-18),与HDI呈负相关(P<.01)。
- 年复发率在幽门螺杆菌感染率极高、高、中、低国家分别为10.9%(95%CI 7-16)、3.7%(95%CI 3-5)、3.4%(95%CI 2-5)和1.6%(95%CI 0.5-3),与感染率呈正相关(P<.01)。
- 全球复发率在1990年代、2000年代和2010年代间保持相对稳定,但不同地区间存在差异(P<.05)。
关键数值与推荐
- 全球年复发率4.3%(95%CI 4-5),年再感染率3.1%(95%CI 2-5),年复燃率2.2%(95%CI 1-3)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Up-to-date information regarding the recurrence rate of Helicobacter pylori (H. pylori) after eradication therapy is not available. AIM: To evaluate the global recurrence rate following H. pylori eradication therapy and confirm its association with socioeconomic and sanitary conditions. METHODS: A systematic search of PubMed, EMBASE and the Cochrane library was performed to identify potentially relevant publications using the following keywords: "Helicobacter pylori" or "H. pylori" or "Hp" and "recurrence" or "recrudescence" or "reinfection" or "recurrent" or "recurred" or "re-infect*" or "relapse*." RESULTS: A total of 132 studies (53 934 patient-years) were analysed. Each study was weighted according to the duration of patient-years. The global annual recurrence, reinfection and recrudescence rate of H. pylori were 4.3% (95% CI, 4-5), 3.1% (95% CI, 2-5) and 2.2% (95% CI, 1-3), respectively. The H. pylori recurrence rate was inversely related to the human development index (HDI) (ie, 3.1% [95% CI, 2-4], 6.2% [95% CI, 4-8] and 10.9% [95% CI, 6-18] in countries with a very high, high and medium or low HDI) (P <.01) and directly related to H. pylori prevalence (10.9% [95% CI, 7-16], 3.7% [95% CI, 3-5], 3.4% [95% CI, 2-5] and 1.6% [95% CI, 0.5-3] in countries with a very high, high, medium or low local H. pylori prevalence) (P <.01). Global recurrence rates remained relatively stable between 1990s, 2000s and 2010s but varied across different regions (P <.05). CONCLUSIONS: H. pylori recurrence remains a problem closely associated with socioeconomic and sanitary conditions. Methods to reduce recurrence in developing countries are needed.
引用
- Hu Y, Wan JH, Li XY, et al. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther. 2017. PMID: 28892184. doi:10.1111/apt.14319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。